Vaxcyte Inc (PCVX)

May 02, 2026

Jennison Associates LLC Has $31.26 Million Stock Position in Vaxcyte, Inc. $PCVX - MarketBeat

May 02, 2026

May 01, 2026

Vaxcyte's Manufacturing-Backed Vaccine Platform Is Redefining The PCV Market - Seeking Alpha

May 01, 2026

May 01, 2026

Vaxcyte COO Jim Wassil sells $127,869 in PCVX shares By Investing.com - Investing.com Canada

May 01, 2026

May 01, 2026

Insider Sell Alert: Jim Wassil Sells Shares of Vaxcyte Inc (PCVX) - GuruFocus

May 01, 2026

May 01, 2026

Vaxcyte (NASDAQ:PCVX) COO Sells $127,867.50 in Stock - MarketBeat

May 01, 2026

May 01, 2026

Vaxcyte COO Jim Wassil sells $127,869 in PCVX shares - Investing.com

May 01, 2026

May 01, 2026

Vaxcyte (PCVX) COO Jim Wassil sells 2,250 shares in Rule 10b5-1 trade - Stock Titan

May 01, 2026

May 01, 2026

PCVX (PCVX) insider James Wassil files planned sales totaling $566,913.91 - Stock Titan

May 01, 2026

May 01, 2026

Vaxcyte Executive Compensation, Directors, and Corporate Governance Overview 2025 - Minichart

May 01, 2026

May 01, 2026

Universal Beteiligungs und Servicegesellschaft mbH Raises Stake in Vaxcyte, Inc. $PCVX - MarketBeat

May 01, 2026

Apr 30, 2026

Vanguard (PCVX) holds 7.25M Vaxcyte shares, reports 5.03% stake - Stock Titan

Apr 30, 2026

Apr 30, 2026

Pictet Asset Management Holding SA Has $40.67 Million Stock Position in Vaxcyte, Inc. $PCVX - MarketBeat

Apr 30, 2026

Apr 29, 2026

Vaxcyte (PCVX) Expected to Announce Quarterly Earnings on Wednesday - MarketBeat

Apr 29, 2026

Apr 27, 2026

Vaxcyte, Inc. (PCVX) Stock Analysis: Exploring the 83% Potential Upside in Vaccine Innovation - DirectorsTalk Interviews

Apr 27, 2026

Apr 26, 2026

Vaxcyte, Inc. (NASDAQ:PCVX) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat

Apr 26, 2026

Apr 25, 2026

Vaxcyte launches proposed $500M public offering of stock, warrants - MSN

Apr 25, 2026

Apr 24, 2026

Vaxcyte Completes Enrollment for Phase 3 VAX-31 Vaccine Trials - HarianBasis.co

Apr 24, 2026

Apr 23, 2026

[ARS] Vaxcyte, Inc. SEC Filing - Stock Titan

Apr 23, 2026

Apr 23, 2026

Vaxcyte (NASDAQ: PCVX) 2026 proxy on directors, auditor and say-on-pay - Stock Titan

Apr 23, 2026

Apr 23, 2026

Vaxcyte Inc (PCVX)’s VAX-31 Enters Critical Trial Stage - Insider Monkey

Apr 23, 2026

Apr 22, 2026

5 Best 52-Week High US Stocks to Buy - Insider Monkey

Apr 22, 2026

Apr 22, 2026

Trading Systems Reacting to (PCVX) Volatility - Stock Traders Daily

Apr 22, 2026

Apr 22, 2026

InvestingPro Fair Value predicted Vaxcyte’s 36% decline By Investing.com - Investing.com South Africa

Apr 22, 2026

Apr 20, 2026

Vaxcyte, Inc. (PCVX) Investor Outlook: A Deep Dive Into Its 74.82% Upside Potential - DirectorsTalk Interviews

Apr 20, 2026

Apr 20, 2026

Vaxcyte (NASDAQ:PCVX) Stock Rating Upgraded by Wall Street Zen - MarketBeat

Apr 20, 2026

Apr 19, 2026

Insiders At Vaxcyte Sold US$1.0m In Stock, Alluding To Potential Weakness - 富途牛牛

Apr 19, 2026

Apr 15, 2026

Needham Maintains Vaxcyte(PCVX.US) With Buy Rating, Maintains Target Price $110 - Moomoo

Apr 15, 2026

Apr 15, 2026

Vaxcyte (PCVX) Stock Insider Selling (Edges Lower) 2026-04-15Large Cap Trends - Cổng thông tin điện tử tỉnh Tây Ninh

Apr 15, 2026

Apr 13, 2026

PCVX Q4 2025 Earnings: Vaxcyte Inc. Misses EPS Estimates, Reports No RevenueExpert Market Insights - UBND thành phố Hải Phòng

Apr 13, 2026

Apr 12, 2026

PCVX Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI

Apr 12, 2026

Apr 12, 2026

Vaxcyte (NASDAQ:PCVX) Stock Rating Lowered by Wall Street Zen - MarketBeat

Apr 12, 2026

Apr 11, 2026

How Vaxcyte Inc. (PCVX) Affects Rotational Strategy Timing - Stock Traders Daily

Apr 11, 2026

Apr 10, 2026

Is It Too Late To Consider Vaxcyte (PCVX) After A 95% One-Year Share Price Jump? - Yahoo Finance

Apr 10, 2026

Apr 10, 2026

What is the target price for Vaxcyte Inc stock2026 Momentum Check & AI Forecasted Entry/Exit Points - baoquankhu1.vn

Apr 10, 2026

Apr 09, 2026

PCVX SEC FilingsVaxcyte, Inc. 10-K, 10-Q, 8-K Forms - Stock Titan

Apr 09, 2026

Apr 09, 2026

Vaxcyte CAO Sells $180,000 in Company Stock - National Today

Apr 09, 2026

Apr 08, 2026

Vaxcyte CAO Sells $180,000 in Stock - National Today

Apr 08, 2026

Apr 08, 2026

Insider Selling: Vaxcyte (NASDAQ:PCVX) CAO Sells 3,000 Shares of Stock - MarketBeat

Apr 08, 2026

Apr 08, 2026

Vaxcyte (PCVX) finance chief sells 3,000 shares after option exercise - Stock Titan

Apr 08, 2026

Apr 08, 2026

Vaxcyte to Present at Annual Healthcare Conference - National Today

Apr 08, 2026

Apr 08, 2026

Vaxcyte Inc stock: Why its pneumococcal vaccine pipeline draws investor focus - AD HOC NEWS

Apr 08, 2026

Apr 08, 2026

Vaxcyte to Present at the 25th Annual Needham Virtual Healthcare Conference - Sahm

Apr 08, 2026

Apr 07, 2026

Elvia Cowan registers 3,000-share sale (PCVX) after option exercise - Stock Titan

Apr 07, 2026

Apr 06, 2026

Vaxcyte (PCVX) Stock Analysis Report | Financials & Insights - Benzinga Japan

Apr 06, 2026

Apr 06, 2026

Vaxcyte, Inc. (PCVX) Investor Outlook: An 86.71% Potential Upside Raises Eyebrows - DirectorsTalk Interviews

Apr 06, 2026

Apr 05, 2026

Aberdeen Group plc Increases Holdings in Vaxcyte, Inc. $PCVX - MarketBeat

Apr 05, 2026

Apr 04, 2026

PCVX.O Technical Analysis & Stock Price Forecast - Intellectia AI

Apr 04, 2026

Apr 04, 2026

PCVX Should I Buy - Intellectia AI

Apr 04, 2026